Unfortunately this is the most probable outcome. Could easily go lower then longer uncertainty goes on because.......
Putting aside all else (holders selling due to frustration with progress and management, the recent spp, shaky US markets etc), the market may now be starting be looking at this for what it is - Just another very early stage pre drilling explorer. If this wasn't on the doorstep of lke then would it be valued at what we are now? We wouldn't.........
Let's quickly think about what's possibly fair. Cash factored in from raise does also help in calculating on valuation (using numbers provided on marketindex), but what seems fair from the following?
0.004 puts us at ~$32 million (Also interesting enough 52 week low)
0.003 puts us at ~$24 million
0.002 at about ~$16 million (I couldn't see this at negative enterprise value but I've seen it before so stranger things have happened)
Right now for what stage we're in terms of our project at 0.004 could easily see the market putting "fair" value - ~$20 million cash plus surely the Carachi and other projects are worth at least a total of $12 million. If the market says no then then next increment down is 0.003......
Just my really quick certainly not in depth thoughts so would be keen to hear how much validity people think this has........
- Forums
- ASX - By Stock
- Ann: Xantippe to Raise up to $20 Million in Placement & SPP
XTC
xtc lithium limited
Add to My Watchlist
0.00%
!
20.0¢

Unfortunately this is the most probable outcome. Could easily go...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $87.6K |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
XTC (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online